Stella Xing

Bio

Stella joined Orbimed in 2021. She is a Managing Director on the Public Equity team in Asia and leads the China research effort. Prior to joining OrbiMed, Stella was Executive Director and lead analyst of China Healthcare Research at UBS. Previously, Stella was Head of China Healthcare Research at Nomura. She graduated from The University of Hong Kong with a BBA degree. Outside the office, Stella enjoys reading history books, cooking dishes, and playing with other people’s dogs.